Male breast cancer experience at Milton Keynes University Hospital over 9 years

Abstract

Introduction: Male breast cancer (MBC) is rare accounting for around 1% of all BC. Familial cases are usually associated with BRCA2 mutation. Ductal carcinoma most common whilst lobular cancer rare. Most hormone receptor positive with 15% showing HER2 overexpression; 4% triple negative.